In vitro and in vivo antibacterial activities of BO-1341, a new antipseudomonal cephalosporin.

Antimicrobial Agents and Chemotherapy
S NakagawaN Tanaka

Abstract

BO-1341, a new antipseudomonal semisynthetic cephalosporin, was evaluated for in vitro and in vivo antibacterial activities in comparison with ceftazidime, cefotaxime, and cefoperazone. The in vitro activity of BO-1341 was generally superior or comparable to the activities of the reference antibiotics against clinical isolates of the family Enterobacteriaceae. BO-1341 was highly active against Pseudomonas aeruginosa (MIC for 90% of the strains tested, 1.56 micrograms/ml), Pseudomonas maltophilia (MIC for 50% of the strains tested, 1.56 micrograms/ml), and Acinetobacter calcoaceticus (MIC for 90% of the strains tested, 3.13 micrograms/ml). Furthermore, BO-1341 was highly active against P. aeruginosa isolates resistant to the other antibiotics. Of 199 P. aeruginosa isolates tested, only 2 were resistant to BO-1341. These two strains were also resistant to ceftazidime, cefotaxime, and cefoperazone. Haemophilus influenzae, Branhamella catarrhalis, and nonenteric streptococci were also susceptible to BO-1341, but Staphylococcus aureus, Streptococcus faecalis, and Bacteroides fragilis were not susceptible to the compound. The protective efficacy against experimental infections in mice caused by nine strains of gram-negative bacteria,...Continue Reading

References

Aug 1, 1979·Antimicrobial Agents and Chemotherapy·H C NeuK Kung
Dec 1, 1979·Antimicrobial Agents and Chemotherapy·N MatsubaraS Mitsuhashi
Jan 1, 1985·Antimicrobial Agents and Chemotherapy·F Yoshimura, H Nikaido
Mar 1, 1989·Antimicrobial Agents and Chemotherapy·K Bush
Mar 1, 1985·The Journal of Infectious Diseases·C C Sanders, W E Sanders
Jul 1, 1987·Antimicrobial Agents and Chemotherapy·S NakagawaN Tanaka
Sep 1, 1980·The Journal of Antimicrobial Chemotherapy·S MitsuhashiS Masuyoshi
Mar 1, 1984·Antimicrobial Agents and Chemotherapy·Y SainoS Mitsuhashi
Dec 1, 1982·Antimicrobial Agents and Chemotherapy·A JaffeO Semonin
Jul 1, 1981·The Journal of Antimicrobial Chemotherapy·I ChopraD C Speller
Sep 1, 1981·The Journal of Antimicrobial Chemotherapy·P B Harper

❮ Previous
Next ❯

Citations

Jan 1, 1992·Diagnostic Microbiology and Infectious Disease·J A García-RodríguezM I García García
May 1, 1995·Diagnostic Microbiology and Infectious Disease·M G Cormican, R N Jones
May 1, 1995·Diagnostic Microbiology and Infectious Disease·D H Wittmann
Sep 8, 1998·Bioorganic & Medicinal Chemistry·N OhtakeS Nakagawa
Jan 1, 1991·Antimicrobial Agents and Chemotherapy·T MaejimaS Mitsuhashi
Jul 2, 2008·Chemical & Pharmaceutical Bulletin·Annett MikolaschUlrike Lindequist
Mar 29, 2019·Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine·Yun-Ming LinMarvin J Miller
Aug 1, 1996·Antimicrobial Agents and Chemotherapy·M Y KimJ H Kwak

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

© 2022 Meta ULC. All rights reserved